Sitemap - May, 2005 - Medical Marketing and Media

Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Email*

Password*

Keep me logged in Forgot your password?

Email*

May, 2005:

Money-back guarantee may be new model in pharma marketing

Testing program finds drugs outlast label expiration date

FDA probes blindness reports among Viagra users

Deadline fast approaching for the MM&M Awards

Medical schools split over drug firm role in research

Merck’s Vioxx liability could reach $18 billion

FDA issues heart risk warning for Serono multiple sclerosis drug

Drug appears to improve vision in seniors

New England Journal of Medicine editor: Pharmas don’t disclose enough trial data

AstraZeneca drug may halt development of world’s fourth leading cause of death

‘Requip XR’ would extend GSK’s patent term: Analyst

CME developer Accelera to join with Romar Consulting

DTC ads spur patient action, ongoing survey says

Diet, health portals are draw as wellness searches swell

Report: cancer drug spend rises, metabolic scripts jump

Company news from the May 20 MM&M News Brief

Account wins from the May 20 MM&M News Brief

Gupta out at AMA

Media People News from the May 20 MM&M News Brief

Supplier People News from the May 20 MM&M News Brief

Agency People News from the May 20 MM&M News Brief

Manufacturer People News from the May 20 MM&M News Brief

Product News from the May 20 MM&M News Brief

During pregnancy, antispsychotics okay while antidepressants are not, studies say

PhRMA seeks DTC detente

Celebrex gains Bextra prescriptions as McKinnell discusses future of both drugs

Pfizer and Genentech present positive cancer drug data at meeting

Wall Street Journal: Lunesta off to strong start

Grey Healthcare’s O’Connor Vos honored at HBA luncheon

McKinnell: Bextra return likely

Parkinson’s drug faulted for gambling addiction in lawsuits

PhRMA floating DTC guidelines draft

Wash. Post: Pentagon reviewing its drug coverage; Nexium first casualty

Metabolic syndrome accounts for 40 percent of Rx spending

Drug makers shore up their guard in wake of ACCME rules

Glaxo places PR business for HIV drugs under review

Company News from the May 6th MM&M News Brief

H&K names Oestreicher to head U.S. pharma practice

Media moves from the May 6th MM&M News Brief

Supplier Moves from the May 6th MM&M News Brief

Agency People Moves from the May 6th MM&M News Brief

Manufacturers People news from the May 6th MM&M News Brief

Product News from the May 6th MM&M News Brief

Gilmartin steps down as Merck chief executive

Cleveland Clinic may end use of J&J’s Natrecor

Despite tone, DTC ads are ‘useful’, Wyeth’s Essner says

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma.